Pressroom

See all trending topics »Trending Topics

Check out the latest cancer-related news and also see who is readily available to offer reliable information, expert commentary, and reaction to today's headlines.
Contact a media coordinator »

First Anti-PD-1 Drug Approved by FDA for Patients with Advanced Melanoma

The first in a new class of immunotherapy drugs was granted FDA approval on September 4, 2014. MSK physicians played a major role in the clinical trials that led to its approval and are continuing to conduct trials using the therapy in melanoma and other cancers.

Friday, September 5, 2014
Memorial Sloan Kettering Study Finds Robotic Surgery No Better Than Open Procedure for Bladder Cancer

Physicians at Memorial Sloan Kettering have found that robotic surgery to remove a cancerous bladder did not reduce the risk of complications as compared with traditional open surgery. Findings were published this week in the New England Journal of Medicine. The study was conducted at MSK with surgeons experienced in both procedures and raises questions about the cost effectiveness of robotic surgery. For more information and to set up interviews with Dr. Bernard Bochner or Dr. Vincent Laudone, please contact Emily O’Donnell at odonnele@mskcc.org.

Thursday, July 24, 2014
Memorial Sloan Kettering Ranks First in the Nation for Cancer Care

Memorial Sloan Kettering is proud and honored to announce it has been named the number one hospital for cancer care in the nation, according to U.S. News & World Report in its annual listing of Best Hospitals. Since the inception of the revered list 25 years ago, MSK has held either the first or second spot each year.

Tuesday, July 15, 2014

See all press releases »Press Releases

Memorial Sloan Kettering Brings Cancer Care Closer to Home for Hudson Valley Residents

Memorial Sloan Kettering’s suburban presence is expanding with its newest and largest state-of-the-art facility set to welcome patients on October 6 in West Harrison, New York.

Wednesday, October 1, 2014
New Academic-Industry Partnership Creates Online Registry for Patients Tested for Inherited Cancer Risk

The Prospective Registry Of Multi-Plex Testing (PROMPT) - a new online, volunteer registry for individuals who have been tested for inherited mutations in cancer-causing genes - will provide data vital to improving our understanding of newly discovered, cancer-associated genes and allow current and future generations to better interpret and benefit from knowledge of their genomes.

Tuesday, September 23, 2014
Hartford HealthCare Cancer Institute Officially Certified as the First Member of the Memorial Sloan Kettering Cancer Alliance

The Hartford HealthCare Cancer Institute has been formally certified as the charter member of the Memorial Sloan Kettering Cancer Alliance, a transformative initiative to improve the quality of care and outcomes for cancer patients in community healthcare settings.

Tuesday, September 16, 2014

See all story starters »Story Starters

Need story ideas? Use our evergreen story suggestions to generate new content or complement something you're already working on.

See all blog posts »On Our Blog

Pictured: Scott Lowe
In the Lab
Researchers Uncover Potential Target for “Undruggable” Form of Liver Cancer

In taking a new approach to finding treatments for hepatocellular carcinoma, MSK scientists have uncovered a potential drug target for this highly aggressive cancer.

Tuesday, September 30, 2014
Support
Solutions for Chemotherapy-Related Nausea and Vomiting

With quick action and the help of the right medicine at the right time, chemotherapy-induced nausea and vomiting can often be prevented, says MSK Nurse Leader Corey Russell.

Monday, September 29, 2014
Event
Transplant Patients Walk Hospital Halls to Support Bone Marrow Donation

Transplant patients at Memorial Sloan Kettering gave support to bone marrow donation efforts with their own “walk” inside the hospital.

Thursday, September 25, 2014

MSK News Highlights

Watch highlights including news coverage of recent scientific and clinical developments at Memorial Sloan Kettering, our physicians and scientists in the national spotlight, and our amazing staff and programs.

Watch Video »

See all media coverage »Media Coverage

Gene Mutation Discovered In Breast Cancer Research

Clinical geneticist Kenneth Offit discussed new findings about a gene called PALB2 that is linked to breast cancer.

Friday, August 8, 2014
Early Stem Cell Transplant Vital in 'Bubble Boy' Disease

Pediatric oncologist Richard O’Reilly discussed a study he led that confirms that transplantation for severe combined immunodeficiency works well in very young children.

Thursday, July 31, 2014
Can Doctors Teach the Body to Cure Cancer?

Medical oncologist Jedd Wolchok discussed immunotherapies that can empower a patient’s immune system to fight cancer.

Monday, July 28, 2014

For Journalists

Contact Media Staff

Jeanne D'Agostino
Media Relations Manager
Emily O'Donnell
Senior Communications Associate, Department of Surgery
Courtney Nowak
Senior Media Relations Associate
Caitlin Hool
Senior Media Associate
Andrea Baird
Media Associate

For press inquiries, our Media Staff are available by calling 646-227-3573 or by dialing the numbers above. Our office hours are Monday - Friday, 9:00 AM to 5:00 PM.

After hours, please contact the hospital's page operator at 212-639-7900 and ask for the Public Affairs representative on-call.

#1 in Cancer Care

MSK Named #1 by U.S. News

News & World Report named Memorial Sloan Kettering the top hospital for cancer care in the nation. We're honored, and patient care will always be our top priority.

Live and Remote Broadcast Capabilities

Our experts can offer live broadcast interviews using the on-site studio system. To book an expert interview using our on-site broadcast studio contact our Media Staff.

Subscribe to Our
E-Newsletter

Our e-mail newsletter for journalists offers the latest advances in cancer research and treatment, including story ideas, institutional milestones and plans, and newsworthy staff accomplishments.

Sign Up

Read recent issues »